Majority of TAMs are associated with Th2 response, secreting IL-10, CCL17, CCL2, CCL22, and TGF-β that favor cancer cell survival, and CCL22 that suppresses antitumor immunity by Treg action [16, 30]. This evidence concerns the gene CCL22 and cancer.